Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TEXAS INSTRUMENTS INC Director's Dealing 2016

Feb 2, 2016

29799_dirs_2016-02-02_f999d206-c0be-459c-bd8a-8e03677de2a1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TEXAS INSTRUMENTS INC (TXN)
CIK: 0000097476
Period of Report: 2016-01-29

Reporting Person: ANDERSON STEPHEN A. (Sr. Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-01-29 Common Stock A 35897 Acquired 235155 Direct
2016-01-29 Common Stock S 18233 $51.89 Disposed 216922 Direct
2016-01-29 Common Stock S 27601 $52.21 Disposed 189321 Direct
2016-02-01 Common Stock M 137500 $32.36 Acquired 326821 Direct
2016-02-01 Common Stock S 137500 $53.0832 Disposed 189321 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-02-01 NQ Stock Option (Right to Buy) $32.36 M 137500 Disposed 2022-01-26 Common Stock (137500) Direct
2016-01-29 NQ Stock Option (Right to Buy) $52.93 A 189828 Acquired 2026-01-29 Common Stock (189828) Direct

Footnotes

F1: Award of restricted stock units pursuant to 2009 Long-Term Incentive Plan.

F2: Sales effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on 7-30-2015. The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $51.05 to $52.04. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price set forth in footnotes (2) and (3) to this Form 4.

F3: Sales effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on 7-30-2015. The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $52.05 to $52.44.

F4: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $53.08 to $53.115. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F5: The option becomes exercisable in four equal annual installments beginning on January 26, 2013.

F6: The option becomes exercisable in four equal annual installments beginning on January 29, 2017.